IMMERAN (Immeran)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspsolution for intravenous administration
Composition:

Active substance: potato sprouts extract (Immerant) - 0.5 mg.

Excipients: sodium chloride - 9 mg; water for injection - up to 1 ml.

Description:

Transparent, colorless or slightly colored liquid, odorless.

Pharmacotherapeutic group:Peptic ulcer treatment of plant origin
ATX: & nbsp
  • Antiulcer drugs and drugs used in gastroesophageal reflux
    • Pharmacodynamics:

    The preparation of Immerant is a fraction from an aqueous extract of potato sprouts (Solanum tuberosum), consisting mainly of polysaccharides (including, including sucrose, arabinose, galactose, uronic acids) and a small amount of protein. The drug normalizes the physiological processes of healing the ulcerative defect by activating the regenerative and reparative processes in the mucous membrane of the stomach and duodenum, improving the spatial structure of the collagen fibers of the submucosal layer, and improving the trophicity of the damaged area of ​​the stomach or duodenum as a result of the formation of additional blood vessels.

    Pharmacokinetics:

    The preparation contains a complex of biologically active substances, therefore it is not possible to carry out pharmacokinetic studies.

    Indications:

    In the complex therapy of peptic ulcer of the stomach and duodenum in the phase of exacerbation, regardless of the presence or absence of Helicobacter pylori infection, as well as the level of acidity of the gastric contents.

    Contraindications:

    Hypersensitivity to the components of the drug (including sucrose, arabinose, galactose, uronic acids, a protein of potatoes); pregnancy, the period of breastfeeding; Children under 18 years of age (due to the lack of results of clinical studies of the drug in pediatrics).

    Pregnancy and lactation:

    The use of the drug during pregnancy and during breastfeeding is contraindicated (due to the lack of data on the safety of the drug in this category of patients).

    If it is necessary to use the drug in women during lactation, breastfeeding should be discontinued.

    Dosing and Administration:

    The drug Immeran should be injected intravenously slowly.

    A single dose is 0.5 mg (the contents of one ampoule of 1 ml of solution).

    The course of treatment - 3 injections for 14 days (on the 1 st, 7 th and 14 th days of treatment).

    Side effects:

    There may be allergic reactions, the appearance of a brief burning sensation and pain at the injection site.

    If any of these side effects are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    Cases of overdose have not been described to date.

    Interaction:

    Interaction with other medicinal products is not described.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the ability to perform potentially dangerous activities requiring increased concentration and speed of psychomotor reactions (vehicle management, work with moving mechanisms, dispatcher and operator work).

    Form release / dosage:

    Solution for intravenous administration, 0.5 mg / ml.

    Packaging:

    1 ml per ampoule of colorless glass.

    3 ampoules per contour mesh package made of polyvinylchloride film.

    1 contour mesh package, together with instructions for use in a pack of cardboard.

    Storage conditions:

    In the dark place at a temperature of 2 to 10 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004128
    Date of registration:08.02.2017
    Expiration Date:08.02.2022
    The owner of the registration certificate:Gemma-B Scientific and Production Company, Ltd.Gemma-B Scientific and Production Company, Ltd. Russia
    Manufacturer: & nbsp
    Information update date: & nbsp05.03.2017
    Illustrated instructions
      Instructions
      Up